A detailed history of Northern Trust Corp transactions in Scholar Rock Holding Corp stock. As of the latest transaction made, Northern Trust Corp holds 620,623 shares of SRRK stock, worth $25.6 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
620,623
Previous 505,224 22.84%
Holding current value
$25.6 Million
Previous $4.21 Million 18.13%
% of portfolio
0.0%
Previous 0.0%

Shares

25 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$7.63 - $9.71 $880,494 - $1.12 Million
115,399 Added 22.84%
620,623 $4.97 Million
Q2 2024

Aug 14, 2024

SELL
$7.84 - $16.79 $83,245 - $178,276
-10,618 Reduced 2.06%
505,224 $4.21 Million
Q1 2024

May 14, 2024

BUY
$13.2 - $17.76 $17,661 - $23,762
1,338 Added 0.26%
515,842 $9.16 Million
Q4 2023

Feb 13, 2024

BUY
$6.52 - $20.32 $685,062 - $2.14 Million
105,071 Added 25.66%
514,504 $9.67 Million
Q3 2023

Nov 13, 2023

BUY
$6.02 - $7.76 $575,969 - $742,445
95,676 Added 30.49%
409,433 $2.91 Million
Q2 2023

Aug 11, 2023

BUY
$5.79 - $9.11 $1.32 Million - $2.08 Million
228,474 Added 267.9%
313,757 $2.37 Million
Q1 2023

May 15, 2023

BUY
$7.36 - $12.72 $18,149 - $31,367
2,466 Added 2.98%
85,283 $682,000
Q4 2022

Feb 13, 2023

BUY
$7.02 - $9.76 $259 - $361
37 Added 0.04%
82,817 $749,000
Q3 2022

Nov 14, 2022

BUY
$5.33 - $11.3 $107,399 - $227,695
20,150 Added 32.17%
82,780 $574,000
Q2 2022

Aug 12, 2022

SELL
$4.66 - $13.96 $901,188 - $2.7 Million
-193,388 Reduced 75.54%
62,630 $344,000
Q1 2022

May 13, 2022

SELL
$11.89 - $24.68 $119,090 - $247,194
-10,016 Reduced 3.76%
256,018 $3.3 Million
Q4 2021

Feb 08, 2022

SELL
$24.14 - $35.18 $178,563 - $260,226
-7,397 Reduced 2.71%
266,034 $6.61 Million
Q3 2021

Nov 15, 2021

SELL
$27.38 - $42.21 $423,048 - $652,186
-15,451 Reduced 5.35%
273,431 $9.03 Million
Q2 2021

Aug 13, 2021

BUY
$26.34 - $46.62 $19,702 - $34,871
748 Added 0.26%
288,882 $8.35 Million
Q1 2021

May 12, 2021

SELL
$45.96 - $68.02 $1.03 Million - $1.52 Million
-22,388 Reduced 7.21%
288,134 $14.6 Million
Q4 2020

Feb 11, 2021

BUY
$13.72 - $51.57 $355,334 - $1.34 Million
25,899 Added 9.1%
310,522 $15.1 Million
Q3 2020

Nov 16, 2020

SELL
$10.54 - $18.47 $165,825 - $290,588
-15,733 Reduced 5.24%
284,623 $5.04 Million
Q2 2020

Aug 14, 2020

BUY
$10.37 - $20.64 $917,309 - $1.83 Million
88,458 Added 41.75%
300,356 $5.47 Million
Q1 2020

May 14, 2020

BUY
$9.63 - $17.14 $67,602 - $120,322
7,020 Added 3.43%
211,898 $2.57 Million
Q4 2019

Feb 14, 2020

SELL
$7.2 - $13.2 $5,637 - $10,335
-783 Reduced 0.38%
204,878 $2.7 Million
Q3 2019

Nov 13, 2019

BUY
$8.95 - $15.72 $298,097 - $523,586
33,307 Added 19.32%
205,661 $1.84 Million
Q2 2019

Aug 13, 2019

BUY
$14.61 - $22.45 $246,222 - $378,349
16,853 Added 10.84%
172,354 $2.73 Million
Q1 2019

May 13, 2019

BUY
$14.24 - $22.28 $1.22 Million - $1.91 Million
85,676 Added 122.7%
155,501 $2.92 Million
Q4 2018

Feb 12, 2019

BUY
$17.86 - $28.77 $67,707 - $109,067
3,791 Added 5.74%
69,825 $1.6 Million
Q3 2018

Nov 14, 2018

BUY
$13.39 - $26.25 $884,195 - $1.73 Million
66,034 New
66,034 $1.7 Million

Others Institutions Holding SRRK

About Scholar Rock Holding Corp


  • Ticker SRRK
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 51,640,600
  • Market Cap $2.13B
  • Description
  • Scholar Rock Holding Corporation, a biopharmaceutical company, focuses on the discovery and development of medicines for the treatment of serious diseases in which signaling by protein growth factors plays a fundamental role. The company develops Apitegromab, an inhibitor of the activation of latent myostatin that has completed the Phase 3 clini...
More about SRRK
Track This Portfolio

Track Northern Trust Corp Portfolio

Follow Northern Trust Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Northern Trust Corp, based on Form 13F filings with the SEC.

News

Stay updated on Northern Trust Corp with notifications on news.